Document is current

Article History

Accepted: 19 April 2022

First Online: 2 June 2022

Declarations

:

: No funding was received for this editorial. The University of Liverpool generously provided the open access publication fee.

: BRB, TA, FA, SLC, FPC, PEE, GH, CK, FL, NS, VS, MAT, and AW have no conflicts to report. BA has worked for GlaxoSmithKline and Novartis, but has no conflicts that are relevant to this editorial. JS has worked for Pfizer and was a government employee between 1980 and 2007.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: BRB drafted the initial text, coordinated the writing, and finalized the revisions of the manuscript. TA, FA, BA, SLC, FPC, PEE, GH, CK, FL, NS, JS, VS, MAT, and AW critically reviewed and revised the manuscript. All authors have read and approved the final submitted manuscript and agreed to be accountable for the work.